I believe in finding the best, most cutting edge treatments to personalize care for my patients

Dr. Pollyea received his MD degree from the University of Chicago Pritzker School of Medicine. He stayed at the University of Chicago Hospital for his residency in Internal Medicine and served as Chief Medical Resident at Cook County Hospital. He then completed his fellowship training in Hematology and Oncology at Stanford University, where he also completed a Masters degree in Epidemiology with an emphasis on biostatistics and clinical trial design. In 2011 he came to the University of Colorado where he is currently the Clinical Director of Leukemia Services. Dr. Pollyea has served as the Principal Investigator of multiple early-phase clinical trials, and has received funding for his work from the American Society of Hematology, the American Society of Clinical Oncology and the Leukemia and Lymphoma Society. He has over 80 peer-reviewed publications and has spoken at many national and international meetings.

Locations

Monday: 8am - 4:30pm
Tuesday: 8am - 4:30pm
Wednesday: 8am - 4:30pm
Thursday: 8am - 4:30pm
Friday: 8am - 4:30pm
Saturday: Closed
Sunday: Closed
Monday: 8am - 5pm
Tuesday: 8am - 5pm
Wednesday: 8am - 5pm
Thursday: 8am - 5pm
Friday: 8am - 5pm
Saturday: Closed
Sunday: Closed

Qualifications and experience

Specialties
Hematology, Medical Oncology, Internal Medicine, Cancers, Blood / Lymphatic System, Cancers - Lymphoma, Cancers - Leukemia (Adult Chronic), Cancers - Leukemia (Adult Acute), Blood / Lymphatic System - Blood Disorders
Gender
Male
Languages spoken
English
Education
Fellowship
Stanford University Program (2010)

Medical School
University of Chicago Division of the Biological Sciences The Pritzker School of Medicine (2003)

Residency
John H Stroger Hospital of Cook County Program (2007)

Residency
University of Chicago Program (2006)

Undergraduate
Indiana University–Bloomington (IN) (1999)

Graduate
Stanford University (2011)

Clinical interest for patients

I am interested in early phase clinical trials for patients with hematological malignancies. I believe in finding the best, most cutting edge treatments to personalize care for my patients.

University of Colorado Blood Cancer and BMT Program Website

Research interest for patients

Dr. Pollyea’s research interests involve developmental therapeutics for myeloid malignancies (myelodysplastic syndromes and acute myeloid leukemia) through collaborative laboratory-based efforts and clinical trials involving novel therapies that he designs and leads. He is interested in developing drugs that target leukemia stem cells that will allow for definitive and curative therapies.

Region
Metro Denver